搜索临床试验以:Phase 2a multiple ascending dose, Anti-Very Late Antigen-1
总计77451个结果
-
Statens Serum Institut完全的
-
Beijing Boren Hospital招聘中复发/复发 | T细胞白血病/淋巴瘤 | 难治性 T 淋巴细胞白血病/淋巴瘤中国
-
Janssen Research & Development, LLC完全的
-
Huazhong University of Science and TechnologyShanghai IASO Biotechnology Co., Ltd尚未招聘慢性淋巴细胞白血病 (CLL) | 外周 T 细胞淋巴瘤 (PTCL) | CD5+ 复发/难治性造血系统恶性肿瘤 | 套细胞淋巴瘤 (MCL) | 弥漫性大 B 细胞淋巴瘤 (DLBCL) | 滤泡性淋巴瘤 (FL)
-
Pathalys PharmaLaunch Therapeutics招聘中
-
Norwegian Institute of Public HealthUniversity of Oslo撤销
-
National Cancer Institute (NCI)完全的IV 期黑色素瘤 | 睫状体和脉络膜黑色素瘤,中号/大号 | 虹膜黑色素瘤 | IIIA期黑色素瘤 | IIIB期黑色素瘤 | IIIC期黑色素瘤 | 眼外扩散黑色素瘤 | IIB期黑色素瘤 | IIC期黑色素瘤美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNYU Langone Health; National Institutes of Health (NIH); Weill Medical College of Cornell University 和其他合作者完全的
-
Lumos DiagnosticsRapid Pathogen Screening完全的
-
Universidad de AntioquiaInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS); Laboratorio... 和其他合作者完全的
-
Shenzhen Geno-Immune Medical InstituteShenzhen Children's Hospital; Shenzhen Hospital of Southern Medical University未知
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Cancer Research UKAleta BioTherapeutics招聘中
-
The Second Hospital of Shandong UniversityShandong Sunstem Biotechnology Co.,Ltd.未知
-
University of Sheffield完全的
-
Chimeric Therapeutics招聘中